Evaluation of Effectiveness and Safety of BioMimeTM stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0003025
- Lead Sponsor
- Chonnam National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
(1) Patient diagnosed with acute coronary syndrome at the age of 19 or older, performing coronary angioplasty with BioMimeTM stent
(2) Patients who voluntarily decide to participate in this research and agree to the consent form
(3) De novo target lesion
Exclusion Criteria
(1) Patients with a taboo or hypersensitivity to anti-diagetic treatment
(2) If the life expectancy is less than two years
(3) Women who are feeding, pregnant, or hoping to conceive
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of failure of target lesions (combination of cardiac death, target vascular myocardial infarction, and ischemia - induced target lesion reconstruction)
- Secondary Outcome Measures
Name Time Method Major cardiac event(death,myocardial infartion,Complex variables in target lesion reconstruction);The incidence of death (cardiac or non-cardiac);Rate of myocardial infarctin(target or non-representative vessels);Rate of target lesion reconstruction (ischemia or non-ischemia);Incidence of target vessel reconstruction;Stroke (ischemia or hemorrhagic) incidence;The incidence of acute stent thrombosis, subacute stent thrombosis, and stent thrombosis after one year.